1Czaja AJ.Behavior and significance of autoantibodies in type 1 autoimmune hepatitis[J].J Hepatol,1999,30:394-401.
2Manns MP,Griffin KJ,Sullivan KF,et al.LKM-1 autoantibodies recognize a short linear sequence in P450IID6,a cytochrome P-450 monooxygenase[J].J Clin Invest,1991,88:1370-1378.
3Wies I,Brunner S,Henninger J,et al.Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis[J].Lancet,2000,355:1510-1515.
4Alvarez F,Berg PA,Bianchi FB,et al.International Autoimmune Hepatitis Group report:review of criteria for diagnosis of autoimmune hepatitis[J].J Hepatol,1999,31:929-938.
6Heathcote EJ.Management of primary billary cirrhosis[J].Hepatology,2000,31 (4):1005-1013.
7Heathcote E J,Cauch-Dudek K,Walker V,et al.The Canadian multicenter double-blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis[J].Hepatology,1994,19:1149-1156.
8Vuoristo M,Farkkila M,Karvonen AL,et al.A placebo-controlled trial of primary biliary cirrhosis treatment with colchicine and ursodeoxycholic acid[J].Gastroenterology,1995,108:1470-1478.
9Neuberger J.Liver transplantation for primary biliary cirrhosis:indications and risk of recurrence[J].J Hepatol,2003,39:142-148.
10Bergquist A,Ekbom A,Olsson R,et al.Hepatic and extrahepatic malignancies in primary sclerosing cholangitis[J].J Hepatol,2002,36:321-327.
